Trust Company of Vermont’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50
| Closed | -$371 | – | 814 |
|
|
2023
Q2 | $371 | Hold |
50
| – | – | ﹤0.01% | 800 |
|
|
2023
Q1 | $473 | Hold |
50
| – | – | ﹤0.01% | 844 |
|
|
2022
Q4 | $533 | Hold |
50
| – | – | ﹤0.01% | 833 |
|
|
2022
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 962 |
|
|
2022
Q2 | $0 | Buy |
+50
| New | – | ﹤0.01% | 890 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | – | – | 338 |
|
|
2021
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 799 |
|
|
2021
Q3 | – | Sell |
-50
| Closed | – | – | 328 |
|
|
2021
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 777 |
|
|
2021
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 757 |
|
|
2020
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 752 |
|
|
2020
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 744 |
|
|
2020
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 739 |
|
|
2020
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 872 |
|
|
2019
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 915 |
|
|
2019
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 988 |
|
|
2019
Q2 | $0 | Buy |
+50
| New | – | ﹤0.01% | 1017 |
|